Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sure, but if the reward outweighs the cost, it’s a no brainer.
Might as well start the what if scenario…..
Then again. I think Missling is too much of a man with honor to take a position where Science and data isn’t top priority.
Imagine that. Buyout in the 8 figures and that spot.
Anavex gets to market, Biogen is in deep trouble R&D wise.
Would have been an awesome ride though from $40-$80 in a matter of a week.
I’m just not willing to gamble with them odds.
It’s also nice to see a lot of the new holdings are in in the low $20s.
At least looking at the ones released this month.
Sorry Pete, I don’t get it.
By 2525 humankind will have long destroyed itself. That’s a whole bother topic though.
Lol still doing that in the twenties? 5’s I’ve heard it, 10’s it was still happening. Teens still going on with the dilution up till now.
Give it a rest or will the same thing happen when we get to the 30’s, 40’s, 50’s?
What a coincidence “by 2025”
No doubt about the last part.
Look at how exciting it is to be back in the 20’s when we never should have been any lower in the first place.
How funny it is that a pump can happen on one stock halting trading only to say “our data is not crooked”
Like they got approved.
Meanwhile, Anavex silently continues to keep its head down and work.
Sure sounding as if we didn’t already get NEVER before seen improvement for both just a few short months ago.
What if it already is approved for multiple CNS diseases already?
What if the data is so unbelievable that even if the FDA tries to delay, Australia still approves?
Sure the past is the past because when you see minute improvement, you need to run another.
If that improvement is life changing/not only stops but improves?
Yea, let’s see how this will play out.
Fun times ahead.
Just trying to stay relevant as they will take months/years to enroll and conclude the trial.
Can’t be quiet or pps drops
Nah, when it first got published no potential was mentioned.
You can still see others that mention the article leave the title as is.
No matter if they do or not, right now they DON’T have it. So it was irresponsible of them to not proof their article.
Here’s an example of the original
https://www.google.com/amp/s/todayuknews.com/entrepreneurs/big-pharma-abandoned-alzheimers-this-good-unicorn-stayed-and-found-a-cure/amp/
I’m pretty positive it said cure yesterday Not potential. Title got edited.
But wait, there’s more……..
If you purchase now, not only will you get the………
Right!
Right……..
That may hold true to BIIB recently approved drug for AD. Heck, it can’t even beat the soc without serious side effects.
Blarcamesine just may be the new SOC for AD, PD, Rett, and probably many others in the next 2-3 years.
Let THAT possibility sink in……..
Bologna
Once we forward split, I’ll think about it.
Exactly. I too believe he is trying to get more tutes invested to help raise the price and resist a hostile situation.
Unfortunately, he can’t build more interest without more data being released.
If he could somehow get that $150M offering secured by some big name……..
Which begs the question…..How much of us here will have sold too early to really realize the full potential of Anavex the BP.
Right….
I’ll liquidate my holdings right away.
Nonsense
“I’ll take no further interest or concerns with PRE-084. In regard to the Anavex drugs and the treatment of CNS diseases, it’s irrelevant.”
Exactly.
Why even try and go down that rabbit hole when it ends up pointless. It is not an Anavex drug so trying to understand why this or why that only distracts from the truly impossible.
Anavex may be on the cusp of treating horrible diseases with a pill.
If we can find ways to identify the condition before it's evident, if we could take a piece of hair and find it, then we could treat it prophylactically and then maybe you don't get it," the 60-year-old actor explained.
Hmmm…. Where have I heard prophylactically from before….
Good for MJF. I hope he achieves his goal of finding a cure.
https://bestlifeonline.com/michael-j-fox-parkinsons-symptoms-news/
And so begins the cycle of FUD.
Glad to read your perspective Falconer.
I don’t know Tred. To date, who has more real outcomes/stories of benefit?
A p2 with, what was it 32 patients, or the hundreds upon hundreds that took the “approved” therapy.
We shall see when the curtain opens.
That makes no sense. AD isn’t even figured in the pps right now, so how can it be overvalued?
Right now it seems like Rett alone as has been stated.
Parkinson’s isn’t even figured either.
What P2 positive top line a few months ago.
AVXL is clearly undervalued no matter how the spin attempts are
Not meaningless.
At least we know you’ll be around longer.
Wow, on it. 5 minutes ago only.
Anavex Life Sciences Reports Data Review by the Independent Data Safety Monitoring Board for its Phase 2b/3 Clinical Trial of ANAVEX®2-73 in Patients with Alzheimer’s Disease
That is correct with Anavex trying to prove it in humans.
You would also be correct that Amyloid was beneficial in mice, and BP is STILL trying to prove that in humans 30 years later.
What’s there to analyze?
That’s what the previous trial was for.
This one should just be a confirmation.
No?
Personally. I’d wait till we reach Monopolyland. Where every quarter, we pass go.
Iceberg comes to mind.
This giant mass of possibilities.
Reading to sink the unsinkable
Hmmmm…. And that actually wasn’t her in the picture walking down the road……..
Changed their name after a failed trial. Few years ago they were supposedly “it”, same position SAVA is in now
“I’m hoping working with Anavex can prove to be beneficial for Batten disease patients. Maybe we could also use this as kind of a model project that we can apply to other rare diseases as well,” Francis said.
Certainly possible…..
https://battendiseasenews.com/2021/03/05/scientist-wins-grant-to-study-cln6-batten-advance-early-trials/
What one calls doubling down, others may call waking up to reality.
They understand time is NOT on their side to get their “crap” approved before a new generation of possible stabilizing/improving therapies DO get approved and render their 10-20-30 years “research” useless.
Seems to be a lot of Sigmar1 research papers floating around lately…….making one beg the question:
WHAT IF!
After watching that, I can see why Missling did what he did with Biogen when MS was still on the trial roadmap.
He was thinking he could collaborate with a BP and all he got was a cold shoulder because Biogen knew what they were up against.
One day……Dr. Christopher Missling TIME magazine man of the year.
Sounds like an easy job for Amazon pharmacy